Objective: To determine the direction of delivery of E-2 in the female pelv
is by assessing the ratio of endometrial to serum E-2 in women whose ovarie
s were stimulated to produce E-2 with women who received exogenous E-2.
Design: Prospective comparative study.
Setting: University-based ART program.
Patient(s): Oocyte donors and recipients of donor oocytes.
Intervention(s): Micronized E-2 administered by the oral or vaginal route a
nd oocyte donation.
Main Outcome Measure(s): Serum and endometrial levels of E-2.
Result(s): Serum E-2 levels were significantly higher in women who underwen
t controlled ovarian hyperstimulation (COH) and women receiving exogenous E
-2 by the vaginal route than in those who received oral E-2. Levels of E-2
in endometrial tissue were similar in women who underwent COH and those rec
eiving oral E-2. Endometrial E-2 levels in women who underwent vaginal admi
nistration were significantly higher than those in the oral E-2 or COH grou
ps. The ratio of endometrial to serum E-2 was highest in women who underwen
t vaginal E-2 and lowest in those undergoing COH.
Conclusion(s): Vaginal administration of micronized E-2 results in preferen
tial absorption of E-2 into the endometrium, consistent with a "uterine fir
st pass" effect. Since endogenous E-2 produced the smallest ratio of E-2 be
tween the endometrium and serum, E-2 produced by the ovaries is not prefere
ntially delivered to the uterus. (Fertil Steril(R) 2001;75:1156-8. (C)2001
by American Society for Reproductive Medicine.).